Pediatric Dermatology Journal Articles

 
 
  • The All Age Asthma Cohort (ALLIANCE) The ALLIANCE cohort study aims to unravel the complex mechanisms behind the development of wheeze and asthma phenotypes across all ages.
  • Keratosis Pilaris and Its Subtypes Keratosis pilaris is a common but poorly understood skin disorder. What's currently known about its etiology, pathophysiology, and genomics; and what are available treatment options?
  • When Is Teenage Plastic Surgery vs Cosmetic Surgery Okay? When it comes to performing plastic surgery on adolescents, what psychological and ethical issues should be considered? Find out what there is to know.
  • Incidence and Prevalence of Rosacea This study aimed to determine the global burden of rosacea. How prevalent is this disease worldwide?
  • Topical Trifarotene: A New Retinoid Trifarotene, a novel fourth-generation topical retinoid, shows favorable preliminary efficacy for acne, and may offer better tolerability than currently available drugs in this class.
  • Methotrexate and Azathioprine for Severe Atopic Dermatitis This study examined the long-term safety, efficacy, and tolerability of azathioprine and methotrexate in adults with moderate-to-severe atopic dermatitis.
  • CVD and T2DM in Adults With Atopic Dermatitis Is atopic dermatitis an independent risk factor for cardiometabolic disease?
  • Antibody Responses Against S. Aureus in Atopic Dermatitis Might an altered immune response towards various S. aureus antigens contribute to inflammation in atopic dermatitis?
  • Dupilumab With Topical Corticosteroids for Atopic Dermatitis Atopic dermatitis patients refractory to topical therapy have few treatment options. This study evaluated the efficacy of the newly approved biologic dupilumab in this difficult-to-treat population.
  • Janus Kinase Inhibitors: Emerging Applications in Dermatology Learn about the use of Janus kinase inhibitors, which have become promising treatment options for dermatologic conditions such as psoriasis, atopic dermatitis, alopecia areata, vilitigo, and more.
  • The Non-neuronal and Nonmuscular Effects of Botulinum Toxin New research suggests that botulinum neurotoxins may have a much wider range of both dermatological and nondermatological applications than originally thought.
  • Management of AD With Dupilumab and Topical Corticosteroids This appraisal of a recent study on the efficacy and safety of long-term therapy with dupilumab, the first USFDA approved biological treatment for moderate-to-severe AD, revealed some concerns.
  • A Hyaluronic Acid-Based Bilaminar Matrix in Wound Beds What benefits might the application of this matrix offer in the healing of complex surgical wounds?
  • Dermatologic Reactions to Immune Checkpoint Inhibitors Immune checkpoint inhibitors are a major breakthrough in cancer therapy, but may cause immune-related dermatologic adverse reactions. How do these commonly manifest and how should they be managed?
  • Habit Reversal Treatment of Scratching in Children With Eczema Can a habit reversal treatment in combination with a steroid offer a superior outcome in the treatment of scratching and eczema in children compared, to a steroid alone?
  • Use of Systemic Corticosteroids for Atopic Dermatitis Despite recommendations against the use of systemic corticosteroids for atopic dermatitis, their use remains widespread. Under what limited circumstances is it appropriate to use them?
  • Are Biologics Efficacious in Atopic Dermatitis? New biologics are promising treatments for atopic dermatitis. This study evaluated currently available biologic therapies for their safety and efficacy in the treatment of this chronic skin disorder.
  • Topical Crisaborole in the Treatment of Atopic Dermatitis While phase III studies of crisaborole have shown it to be a safe treatment that improves symptoms of atopic dermatitis, does it really offer substantive therapeutic benefit over standard therapies?
  • Dupilumab and QoL in Moderate-to-severe Atopic Dermatitis Does dupilumab, a recently approved biologic, improve clinical response and quality of life in adults with moderate-to-severe atopic dermatitis?
  • Hormone Therapy and Patient Satisfaction With Treatment How do patients with disorders of sex development perceive their treatment with hormone replacement therapy? Are they generally satisfied with the experience?